Levent Tabak
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
-
- Tuberculosis Research and Epidemiology
- COVID-19 Clinical Research Studies
Papers in
-
- Sarcoidosis and Beryllium Toxicity Research 4
-
- Pneumothorax, Barotrauma, Emphysema 1
- Co-authors
- Zeki Kılıçaslan (5 shared papers)Mustafa Erelel (2 shared papers)Çağlar Çuhadaroğlu (1 shared paper)Dilek Yılmazbayhan (4 shared papers)Ulrich Costabel (1 shared paper)Feyza Erkan (2 shared papers)Gerhard Hoheisel (1 shared paper)Helmut Teschler (1 shared paper)
In The Last Decade
Levent Tabak
21 papers receiving 261 citations
Peers
Comparison fields: 5 of 66
- Internal Medicine 24
- Infectious Diseases 83
- Obstetrics and Gynecology 18
- Hematology 28
- Physiology 59
Countries citing papers authored by Levent Tabak
This map shows the geographic impact of Levent Tabak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levent Tabak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levent Tabak more than expected).
Fields of papers citing papers by Levent Tabak
This network shows the impact of papers produced by Levent Tabak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levent Tabak. The network helps show where Levent Tabak may publish in the future.
Co-authors
The 25 scholars most cited alongside Levent Tabak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 51 | |
| 2 | 2002 | 48 | |
| 3 | 2020 | 35 | |
| 4 | 2021 | 29 | |
| 5 | 2007 | 22 | |
| 6 | 1994 | 18 | |
| 7 | 2002 | 14 | |
| 8 | 2002 | 12 | |
| 9 | The value of labial biopsy in the differentiation of sarcoidosis from tuberculosis. | 2001 | 9 |
| 10 | 2016 | 6 | |
| 11 | 2007 | 5 | |
| 12 | 2014 | 5 | |
| 13 | 2020 | 5 | |
| 14 | 2005 | 4 | |
| 15 | 2019 | 3 | |
| 16 | 2015 | 3 | |
| 17 | INHERITED THROMBOPHILIC RISK FACTORS IN VENOUSTHROMBOEMBOLISM: FACTOR V LEIDEN AND PROTHROMBIN 20210 A | 2004 | 2 |
| 18 | 2011 | 1 | |
| 19 | Karaciğer Sirozunda Hipoksemi | 1992 | 1 |
| 20 | [Position of occupational diseases in medical education in Turkey]. | 2010 | 1 |
About Levent Tabak
Levent Tabak is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Hematology, Infectious Diseases and Internal Medicine, having authored 23 papers that have together received 275 indexed citations. Recurring topics across this work include Sarcoidosis and Beryllium Toxicity Research (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Endometriosis Research and Treatment (2 papers), Uterine Myomas and Treatments (2 papers), COVID-19 Clinical Research Studies (2 papers), Pneumothorax, Barotrauma, Emphysema (1 paper) and Heparin-Induced Thrombocytopenia and Thrombosis (1 paper). The work is most often cited by research in Internal Medicine (24 citations), Infectious Diseases (83 citations), Obstetrics and Gynecology (18 citations), Hematology (28 citations) and Physiology (59 citations). Levent Tabak has collaborated with scholars based in Türkiye, Norway and Germany. Frequent co-authors include Zeki Kılıçaslan, Mustafa Erelel, Çağlar Çuhadaroğlu, Dilek Yılmazbayhan, Ulrich Costabel, Feyza Erkan, Gerhard Hoheisel, Helmut Teschler, Esen Kıyan and Benan Çağlayan. Their work appears in journals such as Acta Radiologica, Respiratory Medicine, American Journal of Respiratory and Critical Care Medicine, BMC Infectious Diseases and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.